Urokinase-type Plasminogen Activator System and Pancreatic Stellate Cells

Summary

Principal Investigator: Aurelia Lugea
Abstract: [unreadable] DESCRIPTION (provided by applicant): Pancreatic fibrosis is a key feature of alcoholic chronic pancreatitis, a pathology for which effective treatments are currently lacking. To develop rational strategies for the prevention and treatment of pancreatic fibrosis, the regulation of extracellular matrix (ECM) synthesis and degradation needs to be fully understood. Activated pancreatic stellate cells (PSC) are the major source of ECM proteins in fibrotic pancreatic tissues. Pro-inflammatory cytokines and ethanol have been identified as major factors involved in PSC activation. However, the precise mechanisms underlying ethanol-induced PSC activation remain unclear. Extracellular proteolysis associated with the urokinase-type plasminogen activator system (uPA) is increasingly recognized as central to processes including ECM degradation, cell migration, cell adhesion and cell proliferation. Although compelling evidence associates the uPA system with fibrogenesis and inflammation, its participation in pancreas pathology remains largely unknown. In particular, the role of the uPA system in PSC, the main player in pancreatic fibrosis, has not been investigated. Our preliminary studies demonstrate that components of the system (uPA, its receptor uPAR and its specific inhibitor PAI-1) are produced in culture-activated but not in freshly isolated quiescent PSC, suggesting a role for the uPA system in the activated phenotype. Furthermore, addition of known PSC activators such as ethanol or growth factors in the culture medium promotes the activity of uPA. Active uPA in turn activates ECM- degrading proteases such as plasmin and metalloproteases. Therefore, we hypothesize that the uPA system is an important regulator of the activated phenotype in PSCs The system can participate in ECM remodeling through its capacity to break down ECM proteins and activate other ECM-degrading proteases. In addition, the system can modulate cell proliferation, cell migration and cell adhesion through activation of latent growth factors and cytokines and through non-proteolytic functions related with complex interactions with other systems such as integrins and signal transduction via protein kinase cascades. In addition, we hypothesize that ethanol or other factors modify PSC behavior by inducing changes in the uPA system. The specific aims of this proposal are to examine whether known activators such as ethanol and growth factors modulate the expression and activity of the uPA system in rat PSC in culture and to explore the role of the uPA system on PSC responses (activation, proliferation and migration) to growth factors and ethanol. The completion of these objectives will provide insights into the participation of the uPA system in the maintenance of pancreas architecture and in the pathogenesis associated with alcohol abuse. Therapeutic strategies focusing on the regulation of uPA activation may be central in preventing or reverting alcohol-induced pancreas fibrosis. [unreadable] [unreadable] [unreadable]
Funding Period: 2006-09-05 - 2009-08-31
more information: NIH RePORT

Top Publications

  1. pmc Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell
    Stephen Pandol
    Southern California Research Center for Alcoholic Liver and Pancreatic Diseases, University of California and Department of Veterans Affairs, Los Angeles, California, USA
    J Gastroenterol Hepatol 27:127-34. 2012
  2. ncbi Desmoplasia of pancreatic ductal adenocarcinoma
    Stephen Pandol
    Pancreatic Research Group, Department of Medicine, VA Greater Los Angeles Health Care System and University of California, Los Angeles, California, USA
    Clin Gastroenterol Hepatol 7:S44-7. 2009

Scientific Experts

Detail Information

Publications2

  1. pmc Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell
    Stephen Pandol
    Southern California Research Center for Alcoholic Liver and Pancreatic Diseases, University of California and Department of Veterans Affairs, Los Angeles, California, USA
    J Gastroenterol Hepatol 27:127-34. 2012
    ....
  2. ncbi Desmoplasia of pancreatic ductal adenocarcinoma
    Stephen Pandol
    Pancreatic Research Group, Department of Medicine, VA Greater Los Angeles Health Care System and University of California, Los Angeles, California, USA
    Clin Gastroenterol Hepatol 7:S44-7. 2009
    ..A better understanding of the biology of desmoplasia in the mechanism of PDAC will likely provide significant opportunities for better treatments for this devastating cancer...